Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Ophthalmology

The Diagnostic Roadmap: EOG, Imaging, and Genetics

At a Glance

Best vitelliform macular dystrophy (BVMD) is diagnosed using an EOG test to measure the retina's electrical activity, alongside OCT and FAF imaging to visualize yellow material buildup. Genetic testing for the BEST1 gene is essential to confirm the diagnosis and guide family planning.

To get a clear picture of Best Vitelliform Macular Dystrophy (BVMD), doctors use a combination of electrical tests, high-tech photography, and DNA analysis. Because the symptoms can sometimes look like other eye conditions, these tests are the only way to “prove” the diagnosis and help you plan for the future.

Glossary of Key Tests

  • EOG: Electro-oculogram (measures electrical activity of the RPE)
  • OCT: Optical Coherence Tomography (3D scan of retinal layers)
  • FAF: Fundus Autofluorescence (special photography showing glowing waste material)
  • RPE: Retinal Pigment Epithelium (the cell layer that supports the retina)

The “Gold Standard”: The Electro-oculogram (EOG)

The most classic test for Best Disease is the EOG. This test measures the electrical potential (energy) of the RPE, the support layer of your retina [1][2].

During an EOG, you will move your eyes back and forth in both dark and light conditions.

  • The Light Peak: In a healthy eye, the RPE’s electrical activity significantly increases when exposed to light—this is known as the “light peak” [1][3].
  • The Arden Ratio: Doctors compare the eye’s electrical signal in the light versus the dark to calculate the Arden ratio.
    • Normal: Usually 1.8 or higher.
    • Diagnostic for BVMD: A ratio less than 1.5 is the hallmark sign of Best Disease [2][4]. This low ratio occurs because the bestrophin-1 protein (the “gatekeeper” in the RPE) isn’t working correctly, preventing the normal electrical surge in light [1].

Mapping the Retina: OCT and FAF

While the EOG tells doctors how the cells are working, imaging shows them how the cells look.

  • Optical Coherence Tomography (OCT): Think of this as a “biological ultrasound” that uses light to create 3D cross-sections of your retina. It allows doctors to see exactly where the yellow material is building up and whether it is causing the light-sensing cells to lift or thin [5][6].
  • Fundus Autofluorescence (FAF): This specialized camera uses a specific wavelength of light to make certain substances in the eye glow naturally. The yellow “egg yolk” material (lipofuscin) glows very brightly (hyper-autofluorescence) on these scans, allowing doctors to track its size and movement over time [5][7].

The Role of Genetic Testing

Even if your EOG and imaging strongly suggest Best Disease, genetic testing for the BEST1 gene is now considered essential for several reasons [4][8]:

  1. Confirmation: It provides a definitive “yes” or “no” diagnosis, which is critical if your EOG results are borderline [2][4].
  2. Inheritance Pattern: It determines if your condition is autosomal dominant (the common form, BVMD) or autosomal recessive (the rarer form, ARB). This distinction is vital because it tells you the likelihood of passing the condition to your children [9][10].
  3. Family Planning: If a specific mutation is found, your family members can be tested even before they have symptoms, helping them manage their eye health early [11][12].
  4. Clinical Trials: Many emerging treatments are “gene-specific,” meaning you may need proof of a BEST1 mutation to qualify for future research studies or therapies.

Because Best Disease can vary wildly even within the same family, genetic testing helps your care team provide a more personalized roadmap for your vision health [13][14]. Once diagnosed, the primary focus becomes protecting the retina through monitoring, which you can read about in Managing Complications & Care.

Common questions in this guide

What is an EOG test for Best Disease?
An electro-oculogram (EOG) measures the electrical activity of the retina's support layer. In Best Disease, a low electrical response to light, indicated by an Arden ratio of less than 1.5, is the hallmark diagnostic sign of the condition.
What does my Arden ratio mean?
A normal Arden ratio on an EOG test is typically 1.8 or higher. A ratio lower than 1.5 indicates that the bestrophin-1 protein is not working correctly, which strongly points toward Best Vitelliform Macular Dystrophy.
What does an OCT scan show for Best Disease?
Optical Coherence Tomography (OCT) works like a biological ultrasound, creating 3D cross-sections of your retina. It allows eye doctors to see exactly where yellow material is building up and whether it is causing the light-sensing cells to thin or lift.
Why do I need genetic testing if my eye scans already show Best Disease?
While imaging can strongly suggest Best Disease, genetic testing for the BEST1 gene provides a definitive diagnosis. It also identifies your specific inheritance pattern, which helps determine the risk to your family members and your eligibility for future clinical trials.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific Arden ratio, and does it clearly point toward BVMD?
  2. 2.Why should I get genetic testing if my EOG and imaging already suggest Best disease?
  3. 3.How often should we repeat these imaging tests to monitor for changes in my RPE health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.

    Cordes M, Bucichowski P, Alfaar AS, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020; (34(3)):4055-4071 doi:10.1096/fj.201901202RR.

    PMID: 31930599
  2. 2

    A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease.

    Kolesnikova M, Oh JK, Wang J, et al.

    JCI insight 2022; (7(23)).

    PMID: 36264634
  3. 3

    Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations.

    Ji C, Li Y, Kittredge A, et al.

    Scientific reports 2019; (9(1)):19026 doi:10.1038/s41598-019-54892-7.

    PMID: 31836750
  4. 4

    Normal electro-oculography in a young Omani male with genetically confirmed best disease complicated by choroidal neovascularization.

    Al-Abri M, Al-Hinai A, Al Zuhaibi S, et al.

    Oman journal of ophthalmology 2019; (12(1)):37-41 doi:10.4103/ojo.OJO_74_2018.

    PMID: 30787533
  5. 5

    Multimodal imaging in Best Vitelliform Macular Dystrophy: Literature review and novel insights.

    Bianco L, Arrigo A, Antropoli A, et al.

    European journal of ophthalmology 2024; (34(1)):39-51 doi:10.1177/11206721231166434.

    PMID: 36972471
  6. 6

    Correlation of features on OCT with visual acuity and Gass lesion type in Best vitelliform macular dystrophy.

    Coussa RG, Fortenbach CR, Critser DB, et al.

    BMJ open ophthalmology 2021; (6(1)):e000860 doi:10.1136/bmjophth-2021-000860.

    PMID: 34993349
  7. 7

    [Optical coherence tomography and fundus autofluorescence in Best macular dystrophy].

    Chebil A, Charfi H, Largueche L, El Matri L

    Journal francais d'ophtalmologie 2016; (39(6)):543-8.

    PMID: 27206620
  8. 8

    Novel Mutation in BEST1 Associated with Atypical Best Vitelliform Dystrophy.

    Matson ME, Ly SV, Monarrez JL

    Optometry and vision science : official publication of the American Academy of Optometry 2015; (92(8)):e180-9 doi:10.1097/OPX.0000000000000639.

    PMID: 26099059
  9. 9

    Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations.

    Shah M, Broadgate S, Shanks M, et al.

    JAMA ophthalmology 2020; (138(5)):544-551 doi:10.1001/jamaophthalmol.2020.0666.

    PMID: 32239196
  10. 10

    Photoreceptor Function and Structure in Autosomal Dominant Vitelliform Macular Dystrophy Caused by BEST1 Mutations.

    Cideciyan AV, Jacobson SG, Swider M, et al.

    Investigative ophthalmology & visual science 2022; (63(13)):12 doi:10.1167/iovs.63.13.12.

    PMID: 36512348
  11. 11

    Autosomal recessive bestrophinopathy combined with neurofibromatosis type 1 in a patient.

    Zhao B, Chen L, Zhang P, et al.

    BMC ophthalmology 2023; (23(1)):151 doi:10.1186/s12886-023-02905-5.

    PMID: 37041514
  12. 12

    Novel BEST1 Variant Characterization in a Large French Cohort in Light of Updated Bestrophin-1 Structure-Function Correlation.

    Bitan J, Poncet AF, Lecigne C, et al.

    Investigative ophthalmology & visual science 2025; (66(12)):4 doi:10.1167/iovs.66.12.4.

    PMID: 40891781
  13. 13

    NOVEL BEST1 MUTATIONS DETECTED BY NEXT-GENERATION SEQUENCING IN A CHINESE POPULATION WITH VITELLIFORM MACULAR DYSTROPHY.

    Guo J, Gao F, Tang W, et al.

    Retina (Philadelphia, Pa.) 2019; (39(8)):1613-1622 doi:10.1097/IAE.0000000000002183.

    PMID: 29781975
  14. 14

    "Novel p.Tyr284Cys BEST1 genotype-phenotype correlations of Vitelliform Macular Dystrophy in a family with incomplete penetrance".

    Garza-Garza LA, León-Cachón RBR, Aguirre-Garza M, Garza-Leon M

    Ophthalmic genetics 2020; (41(2)):183-188 doi:10.1080/13816810.2020.1744020.

    PMID: 32207364

This page explains diagnostic and genetic tests for Best Disease for educational purposes only. Always consult your ophthalmologist or genetic counselor to interpret your specific test results and inheritance risks.

Get notified when new evidence is published on Best vitelliform macular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.